| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |